Analysis of risk factors for recurrence of differentiated thyroid carcinoma after surgical resection combined with iodine-131 and TSH suppression therapy.
10.13201/j.issn.2096-7993.2023.05.010
- Author:
Ting YE
1
;
Shengwei LAI
2
;
Baolin CAO
1
;
Baixuan XU
1
;
Ruimin WANG
1
Author Information
1. Department of Nuclear Medicine，First Medical Center，PLA General Hospital，Beijing，100853，China.
2. General Surgery，First Medical Center，PLA General Hospital.
- Publication Type:Journal Article
- Keywords:
iodine-131 therapy;
surgical operation;
thyroid neoplasms;
thyroid stimulating hormone
- MeSH:
Humans;
Thyroid Cancer, Papillary/surgery*;
Lymphatic Metastasis/pathology*;
Retrospective Studies;
Neck Dissection;
Thyroidectomy/adverse effects*;
Neoplasm Recurrence, Local/pathology*;
Thyroid Neoplasms/surgery*;
Risk Factors;
Adenocarcinoma;
Thyrotropin;
Lymph Nodes/pathology*
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2023;37(5):370-374
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the risk factors of recurrence after surgical resection of differentiated thyroid carcinoma combined with iodine-131 and TSH（Thyroid stimulating hormone） inhibition therapy. Methods:From January 2015 to April 2020, the clinical data of patients with structural recurrence and without recurrence were retrospectively collected after surgical treatment combined with iodine-131 and TSH inhibition therapy in the First Medical Center of PLA General Hospital. The general conditions of the two groups of patients were analyzed and the measurement data in line with the normal distribution was used for comparison between groups. For measurement data with non-normal distribution, the rank sum test was used for inter-group comparison. The Chi-square test was used for comparison between the counting data groups. Univariate and multivariate regression analyses were used to determine the risk factors associated with relapse. Results:The median follow-up period was 43 months（range 18-81 months） and 100 patients（10.5%） relapsed among the 955 patients. Univariate analysis showed that tumor size, tumor multiple, the number of lymph node metastases>5 in the central region of the neck, and the number of lymph node metastases>5 in the lateral region were significantly correlated with post-treatment recurrence（P<0.001, P=0.018, P<0.001, P<0.001）. Multivariate analysis showed that tumor size（adjusted odds ratio OR: 1.496, 95%CI: 1.226-1.826, P<0.001）, tumor frequency（adjusted odds ratio OR: 1.927, 95%CI: 1.003-3.701, P=0.049）, the number of lymph node metastases in the central neck region>5（adjusted odds ratio OR: 2.630, 95%CI: 1.509-4.584, P=0.001） and the number of lymph node metastases in the lateral neck region>5（adjusted odds ratio OR: 3.074, 95%CI: 1.649-5.730, P=0.001） was associated with tumor recurrence. Conclusion:The study showed that tumor size, tumor multiple, the number of lymph node metastases in the central region of the neck>5 and the number of lymph node metastases in the side of the neck >5 are independent risk factors for recurrence of differentiated thyroid cancer after surgical resection combined with iodine-131 and TSH inhibition therapy.
